News Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Market Closed - Hong Kong S.E. Other stock markets 04:08:13 2024-07-10 am EDT			5-day change	1st Jan Change
9.01 ^HKD	-0.11%		-1.31%	-41.87%

May. 28	China Accepts Boan Biotechnology's Biologics License Application for Type 2 Diabetes Drug	MT
May. 27	Shandong Boan Biotechnology Co., Ltd. Announces Acceptance of BLA in China for Dulaglutide Injection	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Accepts Boan Biotechnology's Biologics License Application for Type 2 Diabetes Drug	May. 28	MT
Shandong Boan Biotechnology Co., Ltd. Announces Acceptance of BLA in China for Dulaglutide Injection	May. 27	CI
Shandong Boan Biotechnology GCTB Drug NMPA's Marketing Approval	May. 27	MT
Shandong Boan Biotechnology Co., Ltd. Announces Approval of Denosumab Injection by the National Medical Products Administration	May. 27	CI
Shandong Boan Biotechnology Co., Ltd. Enters into Loan Facility with China Jingu International Trust Co., Ltd	Apr. 12	CI
Shandong Boan Biotechnology Completes Phase 3 Trial for Retina Injection	Apr. 08	MT
Shandong Boan Biotechnology Co., Ltd. Completes Phase 3 Clinical Trial in China for Aflibercept Intravitreous Injection and Plans to Submit Biologics License Application	Apr. 08	CI
Ocumension Therapeutics' Eye Drug Completes Clinical Trials, to Apply for NDA Soon	Apr. 08	MT
Shandong Boan Biotechnology Trims Attributable Loss in 2023	Mar. 26	MT
Shandong Boan Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Shandong Boan Biotech Completes Phase 3 Trial for Type 2 Diabetes Injection; Shares Surge 10%	Mar. 08	MT
Shandong Boan Biotechnology Co., Ltd. Announces Phase 3 Clinical Trial Completed in China for Dulaglutide Injection	Mar. 07	CI
Shandong Boan Biotechnology Authorizes CDMO Service Provider to Use Stable Cell Line Development Platform	Jan. 30	MT
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with the Zencore Biologics Co., Ltd	Jan. 29	CI
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment	Jan. 29	MT
Shandong Boan Biotechnology Co., Ltd. Announces Orphan Drug Designations for Treatment of Gastric Cancer by FDA	Jan. 24	CI
Boan Biotechnology Secures Brazilian GMP Certification For Cancer Drug	Jan. 18	MT
Shandong Boan Biotechnology Co., Ltd. Obtains GMP Certification for Boyuno®? from the Brazilian Agencia Nacional De Vigilancia Sanitaria	Jan. 17	CI
Boan Biotech Completes Enrollment for International Multicenter Comparative Clinical (Phase 3) Study of Its Denosumab	Jan. 12	CI
Shandong Boan Enrolls Participants for Denosumab Injection Trials in EU, US and Japan	Jan. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Summary

Filters